Learn more

MERISTEM THERAPEUTICS

Overview
  • Total Patents
    57
About

MERISTEM THERAPEUTICS has a total of 57 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are STEMBIOSYS INC, QILU CELL THERAPY TECH CO LTD and STRIDEBIO INC.

Patent filings per year

Chart showing MERISTEM THERAPEUTICSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gruber Veronique 29
#2 Theisen Manfred 20
#3 Rance Iann 11
#4 Bournat Philippe 8
#5 Norre Frederic 8
#6 Merot Bertrand 7
#7 Ruggiero Florence 6
#8 Perret Stephanie 6
#9 Testud Olivier 5
#10 Comeau David 5

Latest patents

Publication Filing date Title
US2006236435A1 Chimeric plant promoters and plants containing the same
EP1403274A1 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby
EP1285965A1 Bifactorial endosperm box, trans-activating factor that binds thereto, and method of regulation of promoter activity
AU4445301A Method for the manufacture of recombinant unhydroxylated collagen polypeptide fibres, and fibres obtained thereby
WO0126450A1 Method for increasing transgenic biomass
AU7307600A Synthetic and chimeric promoters, expression cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them
AU6717700A Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them
AU3316900A Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
WO0056906A1 Chimeric promoters based on the plastocyanin pete promoter from pea
AU2169399A Method for producing, by plant cells, alpha1-antitrypsin and its alleles, and products containing the resulting alpha1-antitrypsin